DrugPatentWatch Database Preview
PRAVASTATIN SODIUM Drug Profile
see a sample report or, see our see our flat-rate plans
When do Pravastatin Sodium patents expire, and what generic alternatives are available?
The generic ingredient in PRAVASTATIN SODIUM is pravastatin sodium. There are sixteen drug master file entries for this compound. Forty-eight suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the pravastatin sodium profile page.
Summary for PRAVASTATIN SODIUM
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 18 |
| Suppliers / Packagers: | 47 |
| Bulk Api Vendors: | 52 |
| Clinical Trials: | 20 |
| Patent Applications: | 4,691 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PRAVASTATIN SODIUM |
| DailyMed Link: | PRAVASTATIN SODIUM at DailyMed |
Pharmacology for PRAVASTATIN SODIUM
| Drug Class | HMG-CoA Reductase Inhibitor |
| Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for PRAVASTATIN SODIUM
Synonyms for PRAVASTATIN SODIUM
| (?R,?R,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-?,?,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt |
| (|AR, |AR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-|A, |A,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic acid sodium hydrate |
| (|AR,|AR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-|A,|A,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic Acid Sodium Salt |
| (betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-beta,delta,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic Acid Na |
| 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, monosodium salt, (1S-(1-alpha(beta-S*,delta-S*),2-alpha,6-alpha,8-beta(R*),8a-alpha))- |
| 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))- |
| 115873-26-2 |
| 3-beta-Hydroxycompactin sodium salt |
| 3beta-Hydroxycompactin, Na |
| 3M8608UQ61 |
| 81093-37-0 (Parent) |
| 81131-70-6 |
| 81131-73-9 |
| 85956-24-7 |
| 87098-76-8 |
| AK150793 |
| AKOS015896504 |
| AKOS015964902 |
| Aplactin |
| Bio-0081 |
| Bristacol |
| C-22432 |
| C23H35NaO7 |
| C23H35O7.Na |
| CAS-81131-70-6 |
| CC-33901 |
| CCG-100926 |
| CHEBI:8361 |
| CHEMBL690 |
| CPD000469187 |
| CRES Pravastatin |
| CS-2003 |
| CS-514 |
| D00893 |
| DRG-0319 |
| DSSTox_CID_27525 |
| DSSTox_GSID_47525 |
| DSSTox_RID_82395 |
| DTXSID6047525 |
| Elisor |
| Epastatin sodium |
| Eptastatin sodium |
| Eptastatin sodium salt hydrate |
| HMS2051P05 |
| HMS3268L20 |
| HY-B0165A |
| I06-2463 |
| Kopostat |
| Lipemol |
| Lipidal |
| Liplat |
| Lipostat |
| Liprevil |
| LS-94711 |
| Mevalotin |
| MFCD00887601 |
| MolPort-003-849-962 |
| NC00176 |
| NCGC00092370-01 |
| NCGC00095183-01 |
| NCGC00254232-01 |
| P1796 |
| Pralidon |
| Prareduct |
| Pravachol |
| Pravachol (TN) |
| Pravacol |
| Pravaselect |
| Pravasin |
| Pravasine |
| Pravastatin (sodium) |
| Pravastatin Natrium Mayrho Fer |
| Pravastatin sodium (JP17/USAN) |
| Pravastatin sodium [USAN:JAN] |
| Pravastatin sodium [USAN:USP:JAN] |
| Pravastatin Sodium Salt |
| Pravastatin sodium salt hydrate |
| Pravastatin sodium salt hydrate, >=98% (HPLC), powder |
| Pravastatin, Sodium Salt |
| PubChem21972 |
| s3036 |
| SAM001246656 |
| Sanaprav |
| SC-46788 |
| SCHEMBL3013 |
| Selektine |
| Selipran |
| Sodium (+)-(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2S)-2-methylbutyrate) |
| sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate |
| sodium;(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate |
| SQ 31000 |
| SQ-31000 |
| ST2407537 |
| Tox21_111474 |
| Tox21_300270 |
| UNII-3M8608UQ61 |
| Vasen |
| VWBQYTRBTXKKOG-IYNICTALSA-M |
US Patents and Regulatory Information for PRAVASTATIN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pliva Hrvatska Doo | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 077730-001 | Nov 21, 2006 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Lupin Pharms | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 077917-004 | Jan 8, 2008 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Sandoz | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 076397-003 | Oct 23, 2006 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Watson Labs | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 076939-001 | Dec 28, 2007 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
